Also known as: Bacillus anthracis antigen
Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Anthrax antigen is the active ingredient of these drugs:
Poland Singapore United Kingdom United States
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):